Literature DB >> 21360040

Variant forms of bladder cancer: basic considerations on treatment approaches.

Francesc Pons1, Anna Orsola, Juan Morote, Joaquim Bellmunt.   

Abstract

Variant forms of bladder cancer are non-urothelial neoplasms or urothelial carcinomas mixed with other histologies. Compared to pure urothelial carcinoma, they all present with a high stage and grade. Prognosis is variable and there is a lack of evidence regarding the ideal treatment approach, because of their relative infrequency and the noninclusion in bladder cancer randomized trials. Despite this, basic recommendations can be extracted from case series. In the present report, existent literature about variant forms of bladder cancer is reviewed with focus on the most frequent: squamous cell, adenocarcinoma, small cell, micropapillary, sarcomatoid, and lymphoepithelioma-like.

Entities:  

Mesh:

Year:  2011        PMID: 21360040     DOI: 10.1007/s11912-011-0161-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  43 in total

1.  Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.

Authors:  J R Mackey; H J Au; J Hugh; P Venner
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

2.  Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.

Authors:  Antonio Lopez-Beltran; Maria J Requena; Jose Alvarez-Kindelan; Ana Quintero; Ana Blanca; Rodolfo Montironi
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

Review 3.  Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.

Authors:  J H Shanks; K A Iczkowski
Journal:  Histopathology       Date:  2008-10-30       Impact factor: 5.087

Review 4.  [Bladder lymphoepithelioma-like carcinoma. Bibliographic review and case report].

Authors:  Gonzalo Bueno Serrano; Fernando Arias Fúnez; Raquel González López; Constantino Varona Crespo; Victor Díez Nicolás; Sara Díaz Naranjo; Angel Escudero Barrilero
Journal:  Arch Esp Urol       Date:  2008 Jul-Aug       Impact factor: 0.436

5.  Treatment of metastatic urachal carcinoma in an elderly woman.

Authors:  Supriya G Mohile; Lori Schleicher; Daniel P Petrylak
Journal:  Nat Clin Pract Oncol       Date:  2008-01

6.  Squamous cell carcinoma of bladder. A review of 114 patients.

Authors:  J S Rundle; A J Hart; A McGeorge; J S Smith; A J Malcolm; P M Smith
Journal:  Br J Urol       Date:  1982-10

7.  Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases.

Authors:  Nikolaj Lagwinski; Anil Thomas; Andrew J Stephenson; Steven Campbell; Aaron P Hoschar; Ehab El-Gabry; Robert Dreicer; Donna E Hansel
Journal:  Am J Surg Pathol       Date:  2007-12       Impact factor: 6.394

8.  Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.

Authors:  Arlene O Siefker-Radtke; Ashish M Kamat; H Barton Grossman; Dallas L Williams; Wei Qiao; Peter F Thall; Colin P Dinney; Randall E Millikan
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

9.  Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?

Authors:  Emil Scosyrev; Jorge Yao; Edward Messing
Journal:  Urology       Date:  2009-02-04       Impact factor: 2.649

10.  Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Authors:  Ashish M Kamat; Colin P N Dinney; Jason R Gee; H Barton Grossman; Arlene O Siefker-Radtke; Pheroze Tamboli; Michelle A Detry; Tracy L Robinson; Louis L Pisters
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

View more
  14 in total

1.  Micropapillary bladder cancer: a clinico-pathological characterization and treatment analysis.

Authors:  Z Li; H Liao; Z Tan; D Mao; Y Wu; Y M Xiao; S K Yang; L Zhong
Journal:  Clin Transl Oncol       Date:  2017-04-21       Impact factor: 3.405

2.  The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy.

Authors:  Qi Tang; Gengyan Xiong; Xuesong Li; Dong Fang; Chenguang Xi; Lei Zhang; Kaiwei Yang; Lin Yao; Cuijian Zhang; Wei Yu; Qun He; Kan Gong; Zhisong He; Liqun Zhou
Journal:  World J Urol       Date:  2015-10-24       Impact factor: 4.226

3.  Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma.

Authors:  Shigeru Sakano; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Yoshitaka Kaneda; Takahito Nasu; Yoshikazu Baba; Tomoyuki Shimabukuro; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; Kazuo Oba
Journal:  Int J Clin Oncol       Date:  2014-06-27       Impact factor: 3.402

4.  Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.

Authors:  Gang Wang; Li Xiao; Miao Zhang; Ashish M Kamat; Arlene Siefker-Radtke; Colin P Dinney; Bogdan Czerniak; Charles C Guo
Journal:  Hum Pathol       Date:  2018-05-12       Impact factor: 3.466

5.  Diagnostic Relevance of GATA 3 Expression in Urinary Bladder Carcinoma of Divergent Differentiation and Other Histological Variants.

Authors:  Chanchal Rana; Suresh Babu; Harshita Agarwal; Atin Singhai; Madhu Kumar; Vishwajeet Singh; R J Sinha; S N Shankhwar
Journal:  Indian J Surg Oncol       Date:  2021-08-18

6.  Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients.

Authors:  N Wagener; J Bulkescher; S Macher-Goeppinger; I Karapanagiotou-Schenkel; G Hatiboglu; M Abdel-Rahim; H Abol-Enein; M A Ghoneim; P J Bastian; S C Müller; A Haferkamp; M Hohenfellner; F Hoppe-Seyler; K Hoppe-Seyler
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

7.  Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder.

Authors:  Hyung Suk Kim; Kyung Chul Moon; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Sci Rep       Date:  2015-05-11       Impact factor: 4.379

8.  Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.

Authors:  Jorge D Ramos; Martin F Casey; Simon J Crabb; Aristotelis Bamias; Lauren C Harshman; Yu-Ning Wong; Joaquim Bellmunt; Ugo De Giorgi; Sylvain Ladoire; Thomas Powles; Sumanta K Pal; Guenter Niegisch; Federica Recine; Ajjai Alva; Neeraj Agarwal; Andrea Necchi; Ulka N Vaishampayan; Jonathan E Rosenberg; Matthew D Galsky; Evan Y Yu
Journal:  Cancer Med       Date:  2016-12-20       Impact factor: 4.452

9.  Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma.

Authors:  Young Ju Lee; Kyung Chul Moon; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

10.  Treating bladder adenocarcinoma.

Authors:  Georgios Tsironis; Aristotle Bamias
Journal:  Transl Androl Urol       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.